v3.26.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Income Statement [Abstract]    
Net sales $ 915,553 $ 2,290,282
Cost of sales 1,304,004 1,389,791
Gross (Loss) Profit (388,451) 900,491
Operating expenses:    
Sales and marketing 621,454 674,582
General and administrative 1,638,833 1,634,965
Research and development costs 127,081 163,469
Total Operating Expenses 2,387,368 2,473,016
Operating Loss (2,775,819) (1,572,525)
Other income (expenses):    
Interest expenses, net (384,851) (99,000)
Change in fair value of derivative liability 214,386
Other income (expenses) (9,198)
Total other expense (170,465) (108,198)
Net Loss (2,946,284) (1,680,723)
Deemed dividend on warrant inducement offer (1,512,480)
Loss Attributed to Common Shareholders $ (4,458,764) $ (1,680,723)
Loss per share - basic before deemed dividend $ (0.11) $ (0.12)
Loss per share - diluted before deemed dividend (0.11) (0.12)
Loss per share (attributable to common shareholders), basic (0.16) (0.12)
Loss per share (attributable to common shareholders), diluted $ (0.16) $ (0.12)
Weighted average shares outstanding - basic 27,346,370 14,271,581
Weighted average shares outstanding - diluted 27,346,370 14,271,581